Skip to content

A clinical study of sutureless technique in correcting high-risk patients with total anomalous pulmonary venous connection

A clinical study of sutureless technique in correcting high-risk patients with total anomalous pulmonary venous connection

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036081
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total anomalous pulmonary venous connection

Interventions

sutureless technique group:sutureless technique
conventional repair group :conventional repair

Sponsors

Shanghai Children's Medical Center,Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Provision of signed and dated informed consent form ( Stated willingness to comply with all study procedures and availability for the duration of the study); 2. Children under 18 years old, regardless of gender; 3. TAPVC patients diagnosed with surgery and at high risk of PVS predicted by the model; 4. The preoperative color Doppler ultrasound indicated that the left ventricular ejection fraction (LVEF) >=50%; 5. For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional 2 years after the end of the study intervention administration; 6. For males of reproductive potential: use of condoms or other methods to ensure effective contraception with partner; 7. Abstain from strenuous exercise for 2 years after surgery. Participants may participate in light recreational activities during studies (e.g., watching television, reading); 8. Abstain from caffeine-,nicotine-, or alcohol-containing products for 2 years after surgery.

Exclusion criteria

Exclusion criteria: 1. TAPVC patients with an anatomical or functional single ventricle; 2. Patients with contraindications to the use of conventional drugs in postoperative care units; 3. Patients fail to undergo cardiac enhanced CT examination; 4. Patients in need of emergency surgery; 5. Patients with preoperative internal environment disorder, acidosis, and multiple organ dysfunction; 6. Patients in remote areas with low follow-up rates; 7. Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
postoperative pulmonary vein stenosis;Postoperative death;adverse event rate;

Secondary

MeasureTime frame
cardiac care unit stay;length of ventilator support;hospital stay;cardiopulmonary bypass time;aortic cross-clamping time;Delayed sternal closure;postoperative low cardiac output syndrome;postoperative diaphragmatic plication;postoperative blood endothelin content;Postoperative CT-based computational hemodynamic indexs (such as shear stress distribution, etc.);Postoperative NYHA grade;Postoperative ECG;Postoperative blood routine;Postoperative liver and kidney function;Blood B-type natriuretic peptide;Troponin;Postoperative chest radiograph;Postoperative cardiac ultrasound;Postoperative heart rate;Postoperative heart rhythm;Postoperative blood pressure;Postoperative blood oxygen saturation;Postoperative blood gas analysis;

Countries

China

Contacts

Public ContactHuiwen Chen

Shanghai Children's Medical Center,Shanghai Jiao Tong University School of Medicine

chenhuiwen@scmc.com.cn+86 18930830797

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026